Ethema Health Corporation released its Q1 2025 quarterly results after experiencing audit review delays that affected filing timelines. The company expects to complete reviews for Q2 and Q3 2025 within the next 30 to 45 days, which will restore its trading status on the OTC-ID market once filings are current.
First quarter revenue showed substantial growth, increasing from $1.300 million to $3.518 million. This growth includes $2.802 million from the recently acquired Aria Kentucky operations, which were integrated beginning January 9, 2025. Existing revenue from Florida operations grew by 10.5% to $1.437 million, marking the first full quarter including revenue from the Boca Raton facility after previous licensing delays were resolved.
Operating expenses increased significantly from $1.529 million to $4.165 million, primarily driven by personnel costs that rose from $0.727 million to $2.063 million. Of this personnel cost increase, $1.178 million relates to Aria Kentucky operations, while the remaining $0.885 million stems from Florida operations, including a full staff complement at the Boca Raton facility. Rental expenses also saw substantial growth from $0.265 million to $0.740 million, with $0.353 million attributable to Kentucky facilities and the remaining increase related to the Boca Raton location.
The combination of increased revenues and higher operating expenses resulted in an operating loss growing from $0.229 million to $0.647 million. However, the company reported improved cash flow utilization in operations, decreasing from $0.106 million to $0.073 million despite the significant acquisition activity and new facility launch. Interest expense and debt discount expense increased from a combined $0.156 million to $0.428 million, primarily due to interest-bearing assumed liabilities and debt funding used for the Aria Kentucky acquisition.
CEO Shawn Leon reported that Florida facilities operated at near capacity in July, while Kentucky facilities reached maximum capacity in their currently online residential facilities by August. The company brought an additional facility in Paducah, Kentucky online in August and expects to activate another dormant residential facility in Morehead, Kentucky in November. Construction is underway on the ARIA Kentucky new head office in Morehead, with completion expected in December 2025.
The company anticipates significant revenue increases in upcoming quarters, projecting approximately 40% growth from Q1 to Q2 2025 and another 10% increase from Q2 to Q3. Operational improvements include successful integration of Kentucky operations and excellent results from a recent Joint Commission audit in Florida. The Kentucky entity will undergo its first CARF accreditation audit at the end of October, continuing the company's focus on quality standards in behavioral healthcare treatment.
This financial reporting comes at a critical time for investors and stakeholders monitoring the behavioral healthcare sector's expansion. The results demonstrate how strategic acquisitions and facility expansions can drive revenue growth while highlighting the operational challenges of integrating new assets and managing increased costs. The company's progress toward restoring full trading status and its projected revenue growth provide important indicators for market participants evaluating investment opportunities in the healthcare sector.
